Association of preventive health care with atherosclerotic heart disease and mortality in CKD

Journal of the American Society of Nephrology

Volumn 20, Issue 7, 2009, Pages 1614-1622

  Snyder, Jon J ^a   Collins, Allan J ^a,b  

^a United States Renal Data System   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE;

ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; HEART DISEASE; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PREVENTIVE MEDICINE; PRIORITY JOURNAL;

EID: 67649777182     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008090954     Document Type: Article

References (28)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007 (Pubitemid 350074801)
2. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39: S1-S266, 2002
3. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT, Jr.: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32: 853-906, 1998
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004 (Pubitemid 39268908)
5. Foley RN, Wang C, Collins AJ: Cardiovascular risk factor profiles and kidney function stage in the US general population: The NHANES III study. Mayo Clin Proc 80: 1270-1277, 2005 (Pubitemid 41395958)
6. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004 (Pubitemid 39258422)
7. U.S. Renal Data System: USRDS 2004 Annual Data Report, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
8. U.S. Renal Data System: USRDS 2003 Annual Data Report, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003, p 124
9. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA: Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 64 [Suppl 87]: S24-S31, 2003 (Pubitemid 37315504)
10. U.S. Renal Data System: USRDS 2002 Annual Data Report, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002, p 116
11. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034-2047, 2006 (Pubitemid 44036188)
12. U.S. Department of Health and Human Services: Healthy People 2010: Understanding and Improving Health, 2nd Ed., Washington DC, U.S. Government Printing Office, 2000
13. Kidney Disease Outcomes Quality Initiative: K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43: S1-S290, 2004
14. National Kidney Foundation: Clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41: S8-S91, 2003
15. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-201, 2003
16. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ: Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63: 738-743, 2003 (Pubitemid 36126822)
17. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK: Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: The TNT (Treating to New Targets) study. J Am Coll Cardiol 51: 1448-1454, 2008
18. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 168: 397-403, 2008 (Pubitemid 351350586)
19. Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH: Identification of individuals with CKD from Medicare claims data: A validation study. Am J Kidney Dis 46: 225-232, 2005 (Pubitemid 41040350)
20. Kern EF, Maney M, Miller DR, Tseng CL, Tiwari A, Rajan M, Aron D, Pogach L: Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res 41: 564-580, 2006 (Pubitemid 43374287)
21. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14: 270-277, 1999
22. U.S. Renal Data System: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007
23. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223-228, 2009
24. U.S. Renal Data System: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007, Figure 1.28, p 75
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987 (Pubitemid 17055592)
26. Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, Solomon DH: Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect. Am J Epidemiol 166: 348-354, 2007 (Pubitemid 47216808)
27. U.S. Department of Health and Human Services. Centers for Medicare and Medicaid Services. Limited Data Sets. 2008. Available at http:// www.cms.hhs.gov/LimitedDataSets. Accessed January 8, 2009
28. Research Data Assistance Center. Medicare Data File Descriptions. 2008. Available at http://www.resdac.umn.edu/Medicare/data-file-descriptions.asp#lds. Accessed January 8, 2009